Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pasireotide Treatment for Insulin Producing Pancreatic Neuro-endocrine Tumor

NCT02779257 is registered in ClinicalTrials.gov with University of Maryland, Baltimore as lead sponsor.

NCT NCT02779257
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02779257 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pasireotide Treatment for Insulin Producing Pancreatic Neuro-endocrine Tumor
Lead sponsor
University of Maryland, Baltimore
Phase
Phase 4
Overall status
Withdrawn
Start date
April 30, 2016
Completion date
June 30, 2016
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

gastro-enteropancreatic neuroendocrine tumor